Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Biodesix (BDSX) Cost of Revenue (2019 - 2025)

Biodesix's Cost of Revenue history spans 7 years, with the latest figure at $11.1 million for Q4 2025.

  • For Q4 2025, Cost of Revenue rose 16.83% year-over-year to $11.1 million; the TTM value through Dec 2025 reached $21.1 million, up 35.63%, while the annual FY2025 figure was $16.7 million, 7.36% up from the prior year.
  • Cost of Revenue reached $11.1 million in Q4 2025 per BDSX's latest filing, up from $4.1 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $18.2 million in Q1 2021 to a low of $1.6 million in Q3 2024.
  • Average Cost of Revenue over 5 years is $4.7 million, with a median of $3.3 million recorded in 2022.
  • The largest YoY upside for Cost of Revenue was 1052.31% in 2021 against a maximum downside of 82.99% in 2021.
  • A 5-year view of Cost of Revenue shows it stood at $2.5 million in 2021, then surged by 32.61% to $3.3 million in 2022, then grew by 2.06% to $3.4 million in 2023, then skyrocketed by 182.04% to $9.5 million in 2024, then grew by 16.83% to $11.1 million in 2025.
  • Per Business Quant, the three most recent readings for BDSX's Cost of Revenue are $11.1 million (Q4 2025), $4.1 million (Q3 2025), and $4.0 million (Q2 2025).